Cargando…

Benefit of Belatacept in Cord Blood-Derived Regulatory T Cell-Mediated Suppression of Alloimmune Response

The role of Regulatory T cells (Tregs) in tolerance induction post-transplantation is well-established, but Tregs adoptive transfer alone without combined immunosuppressants have failed so far in achieving clinical outcomes. Here we applied a set of well-designed criteria to test the influence of co...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xing, Li, Sang, Zhang, Juan, Cao, Lu, Yang, Cejun, Rong, Pengfei, Yi, Shounan, Ghimire, Kedar, Ma, Xiaoqian, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718163/ https://www.ncbi.nlm.nih.gov/pubmed/34570631 http://dx.doi.org/10.1177/09636897211046556

Ejemplares similares

CD27-Expressing Xenoantigen-Expanded Human Regulatory T Cells Are Efficient in Suppressing Xenogeneic Immune Response
por: Cao, Lu, et al.
Publicado: (2023)

Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor–Intolerant Patients
por: Schaenman, Joanna, et al.
Publicado: (2022)

Belatacept in Kidney Transplantation: What Are the True Benefits? A Systematic Review
por: Lombardi, Yannis, et al.
Publicado: (2022)

Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012)

Belatacept: the challenges with transformational drugs
por: Vincenti, Flavio
Publicado: (2017)

PTEN-related risk classification models for predicting prognosis and immunotherapy response of hepatocellular carcinoma
por: Cao, Lu, et al.
Publicado: (2023)

Belatacept: A worthy alternative to cyclosporine?
por: Melvin, George, et al.
Publicado: (2012)

Belatacept for Maintenance Immunosuppression in Lung Transplantation
por: Hui, Christine, et al.
Publicado: (2014)

Belatacept in renal transplantation—quo vadis?
por: Westhoff, Timm H.
Publicado: (2016)

T regulatory cells and the control of alloimmunity: from characterisation to clinical application
por: Wieckiewicz, Joanna, et al.
Publicado: (2010)

The Development and Consequences of Red Blood Cell Alloimmunization
por: Arthur, Connie M., et al.
Publicado: (2023)

Belatacept Conversion in Kidney After Liver Transplantation
por: Cristea, Octav, et al.
Publicado: (2021)

A case of belatacept-induced chilblain lupus
por: Kinariwalla, Neha, et al.
Publicado: (2022)

Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens
por: Ashokkumar, Chethan, et al.
Publicado: (2015)

Reticulocytes in donor blood units enhance red blood cell alloimmunization
por: Thomas, Tiffany A., et al.
Publicado: (2023)

CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”
por: Silva, Marcos V., et al.
Publicado: (2012)

Belatacept and mediastinal histoplasmosis in a kidney transplant patient
por: Trimarchi, Hernán, et al.
Publicado: (2016)

Belatacept in kidney transplant patients with systemic lupus erythematosus
por: Carrión-Barberà, Irene, et al.
Publicado: (2019)

Time-Limited Therapy with Belatacept in Kidney Transplant Recipients
por: Letellier, Thibault, et al.
Publicado: (2022)

Alloimmunization in Thalassemia Patients
por: Joob, Beuy, et al.
Publicado: (2019)

Manipulating IL-2 Availability Amid Presentation of Donor MHC Antigens Suppresses Murine Alloimmune Responses by Inducing Regulatory T Cells
por: Zhang, Shuzi, et al.
Publicado: (2010)

Red blood cell antigen alloimmunization: Mysteries still unsolved
por: Garraud, Olivier
Publicado: (2016)

Posttransplant reduction in preexisting donor‐specific antibody levels after belatacept‐ versus cyclosporine‐based immunosuppression: Post hoc analyses of BENEFIT and BENEFIT‐EXT
por: Bray, R. A., et al.
Publicado: (2018)

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Adult Kidney Transplant Recipients
por: Shen, Jinshan, et al.
Publicado: (2013)

Belatacept As an Alternative to Calcineurin Inhibitors in Patients with Solid Organ Transplants
por: Kumar, Dhiren, et al.
Publicado: (2017)

Belatacept: Coronavirus disease 2019 (COVID-19): case report
Publicado: (2020)

Conversion to belatacept after lung transplantation: Report of 10 cases
por: Brugière, Olivier, et al.
Publicado: (2023)

A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection
por: Perrier, Quentin, et al.
Publicado: (2021)

Foetal and neonatal alloimmune thrombocytopaenia
por: Kaplan, Cecile
Publicado: (2006)

Grand Challenges in Alloimmunity and Transplantation
por: Toubert, Antoine
Publicado: (2011)

Educational Case: Alloimmunization of pregnancy
por: Bastian, Ingmar N., et al.
Publicado: (2022)

Red blood cell and leukocyte alloimmunization in patients awaiting kidney transplantation
por: da Silva, Silvia Fernandes Ribeiro, et al.
Publicado: (2013)

Red blood cell storage and alloimmunization: a fact or a myth?()
por: Castilho, Lilian
Publicado: (2015)

The Impact of Extended Typing On Red Blood Cell Alloimmunization in Transfused Patients
por: Makarovska-Bojadzieva, Tatjana, et al.
Publicado: (2017)

Red blood cell alloimmunization in Iran: A Comprehensive review of the literature
por: Hosseini, Maryam Sadat, et al.
Publicado: (2020)

Ten Years Experience With Belatacept-Based Immunosuppression After Kidney Transplantation
por: Grannas, Gerrit, et al.
Publicado: (2014)

Stricturing Crohn’s disease-like colitis in a patient treated with belatacept
por: Bozon, Anne, et al.
Publicado: (2017)

De Novo Belatacept in a Kidney-After-Heart Transplant Recipient
por: Schenk, Austin D., et al.
Publicado: (2019)

Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020)

Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept
por: Schwarz, Chloë, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4o3mt4q1f6lfa4t2qv79e9qf03